-
Sector Analysis
France Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems
GlobalData’s “France Radiosurgery Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the France Radiosurgery Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - GammaKnife Radiosurgery Systems and Linear Accelerator Radiosurgery Systems The France Radiosurgery Systems Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Sector Analysis
South Korea Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems
GlobalData’s “South Korea Radiosurgery Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the South Korea Radiosurgery Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - GammaKnife Radiosurgery Systems and Linear Accelerator Radiosurgery Systems The South Korea Radiosurgery Systems Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments....
-
Sector Analysis
India Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems
GlobalData’s “India Radiosurgery Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the India Radiosurgery Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - GammaKnife Radiosurgery Systems and Linear Accelerator Radiosurgery Systems The India Radiosurgery Systems Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Sector Analysis
Japan Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems
GlobalData’s “Japan Radiosurgery Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Japan Radiosurgery Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - GammaKnife Radiosurgery Systems and Linear Accelerator Radiosurgery Systems The Japan Radiosurgery Systems Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Sector Analysis
Brazil Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems
GlobalData’s “Brazil Radiosurgery Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Brazil Radiosurgery Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - GammaKnife Radiosurgery Systems and Linear Accelerator Radiosurgery Systems The Brazil Radiosurgery Systems Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided...
-
Thematic Analysis
Impact of the Aging Population on the Medical Industry - Strategic Intelligence
We are experiencing a profound demographic shift as increases in life expectancy—coupled with declines in fertility—have substantially shifted population demographics. According to the World Health Organization (WHO), individuals ages 60 and over will number approximately 2.1 billion by 2050. In high-income countries the challenges of an aging population are particularly pronounced, for example in Japan where close to 30% of the population is aged 60 and over. However, low- and middle-income countries are now experiencing the greatest demographic shift, and...
-
Sector Analysis
Cell and Gene Therapies in CNS Disorders - Disease Overview, Treatment Options and Future Market Assessment
Currently, there are nine cell and gene therapies (CGTs) on the market for various central nervous system (CNS) disorders. This includes three gene therapies, three gene-modified cell therapies, and three conditionally approved cell therapies. Novartis’s Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) was the first CGT asset to receive traditional approval in the CNS market in 2019. Over the past five years, there has been an increase in the number of traditionally approved CGTs for genetic...